Flagging | Investor News and Information | Gentian Diagnostics AS
medical, diagnostics, immunoassays, assays, in vitro diagnostics, IVD products, avian antibodies, antibodies, clinical chemistry, diagnostic tests, biotechnology
16459
post-template-default,single,single-post,postid-16459,single-format-standard,bridge-core-1.0.6,ajax_fade,page_not_loaded,,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-18.2,qode-theme-bridge,wpb-js-composer js-comp-ver-6.0.5,vc_responsive
 

Flagging

Flagging

Oslo, 4 December 2017
Following today’s purchase of 160.000 shares in Gentian Diagnostics, Vatne Equity AS owns 760.000 shares in the Company, corresponding to 5,43% of the outstanding shares. In addition, Lioness AS, a sister company of Vatne Equity AS, has today purchased 100.000 shares in Gentian Diagnostic ASA, corresponding to 0,71% of the outstanding shares. Vatne Equity AS and Lioness AS together own 860.000 shares in Gentian Diagnostics, corresponding to 6,14% of the outstanding shares.
For further information, please contact: Henrik Krefting, CEO (+47) 916 12 279 / Email: hk@vatnecapital.com
MeldingsID440077